Document is current
Any future updates will be listed below
-
Authors
Amemiya, Tsuyoshi
Ouchi, Takehito
Kimura, Hiroo
Okuyama, Kentaro
Phan, Thinh Quang
Iwamoto, Takuji
Nakagawa, Taneaki
Matsumoto, Morio
Nakamura, Masaya
Okano, Hideyuki
Nagoshi, Narihito
Shibata, Shinsuke https://orcid.org/0000-0002-1185-9043
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP25ym0126168)
Japan Agency for Medical Research and Development (JP22bm0704046)
Japan Agency for Medical Research and Development (JP24ym0126118)
Japan Agency for Medical Research and Development (JP24bm1223008)
Japan Agency for Medical Research and Development (JP23hk0102089)
Japan Society for the Promotion of Science (22H03205)
Japan Society for the Promotion of Science (23K24464)
Japan Society for the Promotion of Science (24K19570)
General Insurance Association of Japan
- License Information
-
More Information
Article History
Received: 3 November 2025
Accepted: 21 January 2026
First Online: 11 February 2026
Declarations
:
: The experimental procedures of the project were approved by the Animal Experimentation Ethics Committee of the Keio University. (17024).
: Not applicable.
: H.O. is the Editor in Chief of this journal. H.O. and M.N. are the co-founders, Chief Strategy Officer (CSO), and Chief Technology Officer (CTO), respectively, of K Pharma Inc.
